SCHEMBL14020601

SCHEMBL14020601

C=C(/C=C\C(=C/C)c1ccc([SH](=O)=O)cc1)[SH](=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21613913 0.77 ALDH5A1 (0.32) —
SCHEMBL21893465 0.75 — —
SCHEMBL14081674 0.68 MAPT (0.32) —
SCHEMBL23912108 0.65 TSHR (0.46) —
SCHEMBL20759211 0.64 ALDH1A1 (0.40) —
SCHEMBL20182666 0.62 ALDH1A1 (0.42) —
SCHEMBL14024216 0.61 MAPT (0.50) —
SCHEMBL18598198 0.61 TSHR (0.39) —
SCHEMBL14642359 0.61 MAPT (0.37) —
SCHEMBL13838964 0.59 TSHR (0.63) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1307226-B1 VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS LANTHEUS MEDICAL IMAGING INC (US) 2008-11-19 — — EP disclosed
Send feedback